Loading...
Adherence and Out-of-Pocket Cost Among Medicare Beneficiaries Prescribed Oral Targeted Therapies for Advanced Prostate Cancer
BACKGROUND: Abiraterone and enzalutamide are high-cost oral therapies increasingly used to treat patients with advanced prostate cancer, carrying the potential for significant financial consequences to patients. We investigated coping and material measures of financial hardship of these therapies am...
Na minha lista:
| Udgivet i: | Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7959094/ https://ncbi.nlm.nih.gov/pubmed/32926427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.33176 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|